  Although the immune response is often regarded as acting to suppress tumor
growth, it is now clear that it can be both stimulatory and inhibitory. The
interplay between these competing influences has complex implications for tumor
development and cancer dormancy. To study this biological phenomenon
theoretically we construct a minimally parameterized framework that
incorporates all aspects of the immune response. We combine the effects of all
immune cell types, general principles of self-limited logistic growth, and the
physical process of inflammation into one quantitative setting. Simulations
suggest that while there are pro-tumor or antitumor immunogenic responses
characterized by larger or smaller final tumor volumes, respectively, each
response involves an initial period where tumor growth is stimulated beyond
that of growth without an immune response. The mathematical description is
non-identifiable which allows us to capture inherent biological variability in
tumor growth that can significantly alter tumor-immune dynamics and thus
treatment success rates. The ability of this model to predict immunomodulation
of tumor growth may offer a template for the design of novel treatment
approaches that exploit immune response to improve tumor suppression, including
the potential attainment of an immune-induced dormant state.
